Local and cheaper COVID-19 test kits ready for mass distribution

Published April 20, 2020, 12:00 AM

by manilabulletin_admin

By Dhel Nazario

Manila Health Tek Lab, the company responsible for producing the locally made COVID-19 test kits, targets to produce 16,000 tests per day by May 1, from its daily production capacity of 6,000 to 8,000 tests. It began its mass distribution of the Filipino-made testing kits on Monday.

A Manila Healthek Inc. staff shows the COVID-19 test kit developed by experts from the Philippine Genome Center and the National institute of Health of the University of the Philippines- Manila at press conference at the University of the Philippines Diliman.  (ALVIN KASIBAN / MANILA BULLETIN)
This photo shows the COVID-19 test kit developed by experts from the Philippine Genome Center and the National Institute of Health of the University of the Philippines- Manila at a press conference at the University of the Philippines Diliman. (ALVIN KASIBAN / MANILA BULLETIN)

The University of the Philippines National Institutes of Health (UP-NIH) will be the first health facility to officially use the locally-made COVID-19 test kits after the Manila Health Tek Lab, Inc. delivered the GENAMPLIFY™ Corona Virus Disease-2019 (COVID-19) rRT-PCR test kits to UP-NIH.

After completing the validation studies, this is the manufacturer’s first batch of delivery, under the Field Implementation funded by the Department of Science and Technology (DOST) and Philippine Council for Health Research and Development (PCHRD). The Field Implementation covers 26,000 tests and the total project cost is P53.2 million.

Manila Health Tek, Inc. CEO Dr. Raul Destura expressed gratitude to DOST-PCHRD for funding the production of the test kits and its delivery to the different health facilities in the country.

“As we heal as one in fighting this global pandemic, we thank DOST for its unwavering support in the production of these test kits. We hope that we can serve more Filipinos through this endeavor and help in saving more lives against the scourge of COVID-19,” Dr. Destura said.

Destura said the GENAMPLIFY™ COVID-19 test kit has advantage against its foreign counterparts as it is packaged completely with an RNA extraction device and viral transport medium that is not found in other testing kits.

According to DOST-PCHRD, aside from the complete testing kit package, Dr. Destura guarantees provision of full technical support from their team. Dr. Destura assured that their assistance doesn’t stop in delivering the test kits, laboratory personnel will be provided training on how to conduct the tests using the GENAMPLIFY™ COVID-19 test kit.

The agency added that his team already conducted training with the laboratory personnel of Philippine General Hospital, The Medical City Ortigas, Makati Medical Center, and University of San Agustin, Iloilo City in collaboration with Western Visayas Medical Center and PGC Iloilo.

Destura also emphasized that GENAMPLIFY™ COVID-19 test kit can be used in any RT-PCR machine as the codes used to read the sample is open source.

The complete package of the locally-made test kits inclusive of VAT costs only P1,828.40, almost four times cheaper compared to other kits in the international market whose price may exceed P8,000.

Several institutions have availed of the GENAMPLIFY™ COVID-19 test kit, including the Philippine Genome Center, Bataan General Hospital, Araneta Foundation, Office of the Vice President, and the LGUs of Iloilo, Antipolo, and Pulilan.

“Engaging in the research and development of biotechnology is one our country’s best investment in creating diagnostic tools,” DOST Undersecretary for R&D Rowena Cristina L. Guevara said.

“Through R&D, we have the opportunity to enable our local health sector to be independent, efficient, and be given access to low-cost solutions in managing infectious diseases like COVID-19. I call on our officials and health administrators to support our Pinoy-made test kits,” she added.

DOST Secretary Fortunato T. De la Pena congratulated the PCHRD and the Manila Health Tek, Inc. for responding immediately to the pandemic and coming up with a valuable diagnostic kit.

“The long wait for local test kits is over. We are glad that our very own technology is ready for distribution. With the deployment of the test kits, UP-NIH will increase its capacity to run more tests per day, as each unit of the GENAMPLIFY™ COVID-19 test kit can run 25 tests at once and provide results within two hours,” he said.

 

 
CLICK HERE TO SIGN-UP
 

YOU MAY ALSO LIKE

["news","news"]
[2019845,2874489,2874486,2874482,2874453,2874428,2874404]